Topic Archives: Stansberry’s Investment Advisory

I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

Sometimes when I’m choosing which ad to cover on a given day it’s based on the number of questions I’ve gotten, or the number of times we’ve seen the ad in the past few days… and sometimes it’s based on something that just feels like something interesting. Today it’s the latter… because Brett Aitken and […]

Alzheimer’s Disease always gets a lot of attention from newsletter publishers, readers and investors — not only because we all know someone who suffers from this terrible malady, but because we know that the current treatments are ineffective and the market is huge… which means that any real solutions or more effective treatments could create […]

Porter Stansberry loves to take strong, vocal positions on controversial stocks, and some of those have worked out well. He also rubs a lot of people the wrong way, partly because of his abrasive libertarian screeds and his aggressive marketing campaigns and partly just because he comes across as brash and wealthy. I’ve met with […]

Comments

  • Avatar

    ditto that question Re: Billionaire’s Portfolio https://www.fxtraderprofessional.com/portfolio/...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info